Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents

[1] Byrne RA(2015)Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014 Eur Heart J 36 3320-3331

[2] Joner M(2014)Current treatment of in-stent restenosis J Am Coll Cardiol 63 2659-2673

[3] Kastrati A(2010)In-stent restenosis in the drug-eluting stent era J Am Coll Cardiol 56 1897-1907

[4] Alfonso F(2013)Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography Heart 100 153-159

[5] Byrne RA(2018)Understanding the role of non-coding RNA (ncRNA) in stent restenosis Atherosclerosis. 272 153-161

[6] Rivero F(2013)Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis Science 339 172-177

[7] Kastrati A(2018)Association between insulin resistance and the development of cardiovascular disease Cardiovasc Diabetol 17 122-302

[8] Dangas GD(2014)Insulin resistance and hyperglycaemia in cardiovascular disease development Nat Rev Endocrinol 10 293-675

[9] Claessen BE(2010)Insulin resistance and acute coronary syndrome Atherosclerosis 211 672-10

[10] Caixeta A(2015)Influence of insulin resistance on in-stent restenosis in patients undergoing coronary drug-eluting stent implantation after long-term angiographic follow-up Coronary Artery Dis 26 5-540

[1] Byrne RA(2015)Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014 Eur Heart J 36 3320-3331

[2] Joner M(2014)Current treatment of in-stent restenosis J Am Coll Cardiol 63 2659-2673

[3] Kastrati A(2010)In-stent restenosis in the drug-eluting stent era J Am Coll Cardiol 56 1897-1907

[4] Alfonso F(2013)Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography Heart 100 153-159

[5] Byrne RA(2018)Understanding the role of non-coding RNA (ncRNA) in stent restenosis Atherosclerosis. 272 153-161

[6] Rivero F(2013)Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis Science 339 172-177

[7] Kastrati A(2018)Association between insulin resistance and the development of cardiovascular disease Cardiovasc Diabetol 17 122-302

[8] Dangas GD(2014)Insulin resistance and hyperglycaemia in cardiovascular disease development Nat Rev Endocrinol 10 293-675

[9] Claessen BE(2010)Insulin resistance and acute coronary syndrome Atherosclerosis 211 672-10

[10] Caixeta A(2015)Influence of insulin resistance on in-stent restenosis in patients undergoing coronary drug-eluting stent implantation after long-term angiographic follow-up Coronary Artery Dis 26 5-540